News
Here are the latest rating downgrades by Seeking Alpha analysts: British American Tobacco (NYSE:BTI). Hold to sell by Michael ...
Hims & Hers achieved 136% YoY subscriber growth and unveiled ambitious 2030 goals. Discover how precision medicine drives ...
Hims & Hers Health Inc (NYSE:HIMS) shares are falling Thursday morning after the company announced a proposed convertible ...
The decline in Hims & Hers’ stock price comes as the market reacts to the potential dilution of shares resulting from the ...
Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
A post-earnings rally in Hims & Hers Health Inc. has turned co-founder and Chief Executive Officer Andrew Dudum into a weight-loss billionaire.
Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...
Hims & Hers Health shares have surged 32.4% since Tuesday's session open. The stock is gaining following a standout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results